AMP 579 + cariporide: additive cardioprotection in rabbits

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1362, 2002-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous AMP 579, a novel adenosine A 1 /A 2a receptor agonist, induces a delayed protection against myocardial infarction in minipig

By Meng H. McVey M. Perrone M. Clark K.L.

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 101-105

Elsevier

Access to resources Recommend Favorite

A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium

By Nakamura M. Zhao Z.-Q. Clark K.L. Velez D.V. Guyton R.A. Vinten-Johansen J.

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 197-205

Elsevier

Access to resources Recommend Favorite

Kinins and Cardioprotection

By Wirth K.J. Linz W. Wiemer G. Scholkens B.A.

Pharmacological Research, Vol. 35, Iss. 6, 1997-06 ,pp. : 527-530

Academic Press

Access to resources Recommend Favorite

Sildenafil and Cardioprotection

Current Pharmaceutical Design, Vol. 19, Iss. 39, 2013-12 ,pp. : 6842-6847

Bentham Science Publishers

Access to resources Recommend Favorite

Cardioprotection in the Clinical Setting

By Ivanes Fabrice Mewton Nathan Rioufol Gilles Piot Christophe Elbaz Meyer Revel Didier Croisille Pierre Ovize Michel

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 281-287

Springer Publishing Company

Access to resources Recommend Favorite